🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fluticasone plus salmeterol fixed combination

Found 35 matching trials

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD

This is a randomized, multi-center, active-controlled, repeated measures de...

Status

Completed

Location

3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa

Start Date

2016-04

Trial ID

NCT02757209

Treatments Being Tested

Spiromax (budesonide/formoterol)Turbohaler (budesonide/formoterol)Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

PHASE2

The primary objective of this study is to evaluate the dose response, effic...

Status

Completed

Location

Teva Investigational Site 10453

Start Date

2013-01

Trial ID

NCT01772368

Treatments Being Tested

Fp MDPI FS MDPI Advair Diskus Albuterol

Atlantis Symbicort

PHASE3

The purpose of this study is to determine whether Symbicort compared with A...

Status

Completed

Location

Multiple Locations

Start Date

2003-11

Trial ID

NCT00646594

Treatments Being Tested

budesonide/formoterol (Symbicort)fluticasone/salmeterol (Advair)

Asthma Research in Children and Adolescents

N/A

The purpose of this study is to assess the evolution of disease control, he...

Status

Active Not Recruiting

Location

Centro de Salud de Jerez Sur

Start Date

2017-07-26

Trial ID

NCT04480242

Treatments Being Tested

Inhaled Corticosteroids (ICs)Fixed-Dose Combination of Inhaled Corticosteroids and Long- Acting Beta-agonist (ICs/LABA)Other treatments Inhaler device Regularly monitoring of the Inhalation technique through mobile app

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

PHASE4

The primary objective of the trial is to show superiority in lung function ...

Status

Completed

Location

Jasper Summit Research, LLC

Start Date

2017-08-14

Trial ID

NCT03240575

Treatments Being Tested

Tiotropium Olodaterol Fluticasone propionate Salmeterol

Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.

PHASE2

The purpose of this study is to assess peak FEV1 of two doses of QVM149 com...

Status

Completed

Location

Novartis Investigative Site

Start Date

2017-01-21

Trial ID

NCT03063086

Treatments Being Tested

QVM149 150/50/80 μg o.d.QVM149 150/50/160 μg o.d.salmeterol/fluticasone FDC 50/500 μg b.i.d.

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

N/A

To evaluate COPD-related clinical outcomes and total healthcare utilization...

Status

Completed

Location

Multiple Locations

Start Date

2009-07

Trial ID

NCT01331694

Treatments Being Tested

fluticasone/salmeterol combination (FSC) 250/50mcg tiotropium ipratropium bromide alone or in fixed dose combination with albuterol

Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients

PHASE3

The objective of the trial is to compare the lung function profile of once ...

Status

Completed

Location

1237.11.32002 Boehringer Ingelheim Investigational Site

Start Date

2013-10

Trial ID

NCT01969721

Treatments Being Tested

fluticasone propionate salmeterol placebo placebo tiotropium olodaterol olodaterol placebo placebo tiotropium fluticasone propionate salmeterol

Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This study will evaluate the onset of action of indacaterol (150 and 300 µg...

Status

Completed

Location

Novartis Investigative Site

Start Date

2008-04

Trial ID

NCT00669617

Treatments Being Tested

Indacaterol Salmeterol/fluticasone (50/500 μg)Salbutamol (200 µg)Placebo to Indacaterol Placebo to Salmeterol/fluticasone Placebo to salbutamol

Previous Next